FUNCTIONAL GENOMICS CORE
功能基因组核心
基本信息
- 批准号:7777675
- 负责人:
- 金额:$ 11.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisAreaBindingBioinformaticsBiological ProcessBudgetsCellsChemotaxisClinicalCollectionCommitCommunitiesComplexCore FacilityDNA Microarray ChipDNA-Binding ProteinsDatabasesDevelopmentDigestive System DisordersDiseaseEquipmentEventExpressed Sequence TagsFundingFungal GenomeGene ExpressionGenesGenetic TranscriptionGenomeHepaticHumanHuman Genome ProjectHuman ResourcesInflammationInstitutionInvestigationInvestmentsLaboratoriesLibrariesLigandsLogicMalignant NeoplasmsMatrix MetalloproteinasesMeasuresMethodologyMethodsMicroRNAsMolecular ProfilingMonitorMorphologyMusNational Institute of General Medical SciencesOligonucleotidesPathologyPhysiological ProcessesPolysaccharidesProcessProtein ArrayProtein-Carbohydrate InteractionRattusResearchResearch PersonnelResourcesRoleSamplingServicesStreptavidinStructureTechnologyTimeTissue BankingTissue BanksTissue ProcurementsTissuesTrainingUniversitiesVirus DiseasesWashingtonWorkangiogenesisarmbasecDNA Arrayschromatin immunoprecipitationcostcost effectivedensitydesignexperiencefunctional genomicsfunctional groupgastrointestinalgenome sequencinginstrumentationlipid metabolismprogramspromoter
项目摘要
The Human Genome Project and the development of the expressed sequence tag (EST) clone collection
and database have revolutionized gene expression analysis. Instead of measuring one or a few genes, parallel
DNA microarrays are capable of simultaneously measuring expression of thousands of genes, providing a
glimpse into the logic and functional grouping of gene programs encoded by our genome. The term functional
genomics encompasses varied approaches that provide a more global investigation into the expression and
role of groups of genes in a physiologic process than has been previously available. As such, this approach
represents a fundamental shift from the traditional 'one gene at a time' approach to the study of basic biological
processes. cDNA microarrays and oligonucleotide-based microarray methodologies have the potential to
provide a new level of information about cell or tissue function not previously possible. However, these
technologies require an investment in expensive equipment and highly trained, experienced technicians. Most
laboratories cannot afford to commit the substantial technical resources and personnel to the development and
ongoing refinement of these particularly complex experimental methods. It is more cost effective to concentrate
this instrumentation and highly skilled technical support in a centrally managed facility, where they will be
efficiently utilized and cost effective. The Functional Genomics Core Facility was designed to provide this
critical core expertise to the digestive disease research community.
The unique feature of the Functional Genomics Core Facility is the expertise it provides to participating
investigators on the application of high density comprehensive arrays to study gastrointestinal and hepatic
qene expression. In maintaining an independent microarray core, DDRCC research investigators are provided
with access to the Agilent platforms at extremely low costs ($275/2 sample comparisons using the 44K gene
arrays) and with much more rapid turn around time (<5 days) than other microarray facilities in the institution.
The close proximity of the Functional Genomics Core to the DDRCC Morphology Core and the DDRCC Tissue
Procurement Facility greatly facilitates the processing and analysis of clinical samples related to digestive
disease disorders. The DDRCC Functional Genomics Core works closely with other microarray facilities at this
institution that offer alternative commercial platforms, such as the Affymetrix platforms supported by the CTSA
sponsored Translational Pathology and Tissue Banking Core, and the Illumina platforms supported by the
Genome Sequencing Center of Washington University. Important for tight budgets, the cost of our services is
less than half the cost of a single sample Affy array, and is about 20% less than the Illumina platform. Just as
important, the Functional Genomics Core provides integrative and bioinformatic services.
人类基因组计划和表达序列标签 (EST) 克隆集合的开发
和数据库彻底改变了基因表达分析。不是测量一个或几个基因,而是平行测量
DNA 微阵列能够同时测量数千个基因的表达,提供
一睹我们基因组编码的基因程序的逻辑和功能分组。术语功能性
基因组学涵盖了多种方法,可以对表达和表达进行更全面的研究
基因组在生理过程中的作用比以前可用的更深入。因此,这种方法
代表了从传统的“一次一个基因”方法到基础生物学研究的根本转变
流程。 cDNA 微阵列和基于寡核苷酸的微阵列方法有潜力
提供有关细胞或组织功能的新水平的信息,这在以前是不可能的。然而,这些
技术需要投资昂贵的设备和训练有素、经验丰富的技术人员。最多
实验室无法投入大量的技术资源和人员来开发和
不断完善这些特别复杂的实验方法。集中精力更划算
这些仪器和高技能的技术支持在一个集中管理的设施中,他们将在那里
有效利用且具有成本效益。功能基因组学核心设施旨在提供这一服务
消化疾病研究界的关键核心专业知识。
功能基因组学核心设施的独特之处在于它为参与项目提供的专业知识
研究人员应用高密度综合阵列研究胃肠道和肝脏
qene 表达式。在维持独立的微阵列核心方面,DDRCC 研究人员提供了
可以以极低的成本访问安捷伦平台(使用 44K 基因进行 275 美元/2 个样品比较
阵列),并且比该机构中的其他微阵列设施具有更快的周转时间(<5 天)。
功能基因组学核心与 DDRCC 形态学核心和 DDRCC 组织非常接近
采购设施极大地方便了消化相关临床样本的处理和分析
疾病失调。 DDRCC 功能基因组核心与其他微阵列设施密切合作
提供替代商业平台的机构,例如 CTSA 支持的 Affymetrix 平台
赞助的转化病理学和组织库核心,以及由
华盛顿大学基因组测序中心。对于预算紧张来说很重要,我们的服务成本是
单个样品 Affy 阵列的成本不到一半,比 Illumina 平台低约 20%。正如
重要的是,功能基因组学核心提供综合和生物信息服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN Keith DIECKGRAEFE其他文献
BRIAN Keith DIECKGRAEFE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN Keith DIECKGRAEFE', 18)}}的其他基金
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
结肠癌中的新型 Reg4-CD44 信号通路
- 批准号:
9339585 - 财政年份:2015
- 资助金额:
$ 11.49万 - 项目类别:
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
结肠癌中的新型 Reg4-CD44 信号通路
- 批准号:
9795436 - 财政年份:2015
- 资助金额:
$ 11.49万 - 项目类别:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
IBD 中集落刺激因子的作用机制
- 批准号:
7263699 - 财政年份:2007
- 资助金额:
$ 11.49万 - 项目类别:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
IBD 中集落刺激因子的作用机制
- 批准号:
8050129 - 财政年份:2007
- 资助金额:
$ 11.49万 - 项目类别:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
IBD 中集落刺激因子的作用机制
- 批准号:
7406643 - 财政年份:2007
- 资助金额:
$ 11.49万 - 项目类别:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
IBD 中集落刺激因子的作用机制
- 批准号:
7585280 - 财政年份:2007
- 资助金额:
$ 11.49万 - 项目类别:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
IBD 中集落刺激因子的作用机制
- 批准号:
7796657 - 财政年份:2007
- 资助金额:
$ 11.49万 - 项目类别:
EXPRESS REGENERATING GENE FAMILY IN IBD MUCOSA REG IA UPREGULATION
IBD 粘膜 REG IA 上调中的表达再生基因家族
- 批准号:
7180057 - 财政年份:2005
- 资助金额:
$ 11.49万 - 项目类别:
EXPRESS REGENERATING GENE FAMILY IN IBD MUCOSA REG IA UPREGULATION
IBD 粘膜 REG IA 上调中的表达再生基因家族
- 批准号:
6977024 - 财政年份:2003
- 资助金额:
$ 11.49万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 11.49万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 11.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 11.49万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 11.49万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




